Literature DB >> 18215007

A novel 'peak parking' strategy for ultra-performance liquid chromatography/tandem mass spectrometric detection for enhanced performance of bioanalytical assays.

Fumin Li1, Jacob Maguigad, Mary Pelzer, Xiangyu Jiang, Qin C Ji.   

Abstract

Sensitive and high-throughput bioanalytical assays are of vital importance to drug discovery and development. Ultra-performance liquid chromatography (UPLC), utilizing sub-2-microm particles, greatly increases the separation throughput and efficiency, resulting in LC peaks as narrow as or less than 1 s (full width at half maxima, FWHM). This, however, could pose practical challenges for bioanalytical applications using quadrupole mass spectrometry (MS) to acquire sufficient data points to ensure accurate and reliable quantitation. Here, we present a novel 'peak parking' strategy to reduce the flow rate during UPLC peak elution, therefore extending the useful MS acquisition window. The high-throughput advantage of UPLC is maintained since no significant increase of the overall UPLC run time is needed. This strategy was demonstrated in an assay development for lansoprazole, a gastric proton-pump inhibitor, in human plasma employing liquid-liquid extraction. The method was validated from 50.0 to 50,000 pg/mL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18215007     DOI: 10.1002/rcm.3389

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  3 in total

1.  Novel three-dimensional MALDI plate for interfacing high-capacity LC separations with MALDI-TOF.

Authors:  Stephen J Hattan; Marvin L Vestal
Journal:  Anal Chem       Date:  2008-12-01       Impact factor: 6.986

2.  Simultaneous determination of reserpine, rescinnamine, and yohimbine in human plasma by ultraperformance liquid chromatography tandem mass spectrometry.

Authors:  Muzaffar Iqbal; Aftab Alam; Tanveer A Wani; Nasr Y Khalil
Journal:  J Anal Methods Chem       Date:  2013-12-05       Impact factor: 2.193

3.  Simple, sensitive and rapid determination of linifanib (ABT-869), a novel tyrosine kinase inhibitor in rat plasma by UHPLC-MS/MS.

Authors:  Muzaffar Iqbal; Essam Ezzeldin; Tanveer A Wani; Nasr Y Khalil
Journal:  Chem Cent J       Date:  2014-02-17       Impact factor: 4.215

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.